Publications by authors named "Tetsushi Mimura"

Claim this Profile
S
Safety and Tolerability of Adipose-Derived Mesenchymal Stem Cell (ADR-001) Therapy for IgA Nephropathy.
Akihito Tanaka, Kazuhiro Furuhashi, Kumiko Fujieda, Asuka Horinouchi, Kayaho Maeda, Tetsushi Mimura

Kidney360· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Proton Pump Inhibitor Therapy Increases the Risk of Infection in Patients with Incident Hemodialysis.
Yosuke Saka, Tomohiko Naruse, Taiki Chikamatsu, Kotaro Mitani, Mako Hayashi, Tetsushi Mimura

Nephron· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Duration of SARS-CoV-2 antigen positivity in hemodialysis patients.
Jun Matsumoto, Yosuke Saka, Tetsushi Mimura, Tomohiko Naruse

Ren Fail· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deep learning analysis of clinical course of primary nephrotic syndrome: Japan Nephrotic Syndrome Cohort Study (JNSCS).
Tomonori Kimura, Ryohei Yamamoto, Mitsuaki Yoshino, Ryuichi Sakate, Enyu Imai, Tetsushi Mimura

Clin Exp Nephrol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Two cases of ceftriaxone-induced encephalopathy treated by hemoperfusion in hemodialysis patients.
Chikao Onogi, Akinori Osada, Kentaro Imai, Tetsushi Mimura, Yosuke Saka

Hemodial Int· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Time to remission of proteinuria and incidence of relapse in patients with steroid-sensitive minimal change disease and focal segmental glomerulosclerosis: the Japan Nephrotic Syndrome Cohort Study.
Ryohei Yamamoto, Enyu Imai, Shoichi Maruyama, Hitoshi Yokoyama, Hitoshi Sugiyama, Tetsushi Mimura

J Nephrol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protocol for a Phase 1, Open-Label, Multiple-Center, Dose-Escalation Study to Evaluate the Safety and Tolerability of ADR-001 in the Treatment of Immunoglobulin A Nephropathy.
Akihito Tanaka, Kazuhiro Furuhashi, Kumiko Fujieda, Kayaho Maeda, Shoji Saito, Tetsushi Mimura

Front Med (Lausanne)· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low Serum Zinc Concentration Is Associated With Infection Particularly in Patients With Stage 5 Chronic Kidney Disease Medicated with Proton Pump Inhibitors.
Yosuke Saka, Tomohiko Naruse, Jun Matsumoto, Yuka Takeda, Chikao Onogi, Tetsushi Mimura

J Ren Nutr· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Better remission rates in elderly Japanese patients with primary membranous nephropathy in nationwide real-world practice: The Japan Nephrotic Syndrome Cohort Study (JNSCS).
Hitoshi Yokoyama, Ryohei Yamamoto, Enyu Imai, Shoichi Maruyama, Hitoshi Sugiyama, Tetsushi Mimura

Clin Exp Nephrol· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence of remission and relapse of proteinuria, end-stage kidney disease, mortality, and major outcomes in primary nephrotic syndrome: the Japan Nephrotic Syndrome Cohort Study (JNSCS).
Ryohei Yamamoto, Enyu Imai, Shoichi Maruyama, Hitoshi Yokoyama, Hitoshi Sugiyama, Tetsushi Mimura

Clin Exp Nephrol· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regional variations in immunosuppressive therapy in patients with primary nephrotic syndrome: the Japan nephrotic syndrome cohort study.
Ryohei Yamamoto, Enyu Imai, Shoichi Maruyama, Hitoshi Yokoyama, Hitoshi Sugiyama, Tetsushi Mimura

Clin Exp Nephrol· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thiamine status in end-stage chronic kidney disease patients: a single-center study.
Yosuke Saka, Tomohiko Naruse, Akihisa Kato, Naoto Tawada, Yuhei Noda, Tetsushi Mimura

Int Urol Nephrol· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Successful rituximab treatment of TAFRO syndrome with pathological findings of glomerular endothelial damage.
Yuhei Noda, Yosuke Saka, Akihisa Kato, Tetsushi Mimura, Tomohiko Naruse

Clin Nephrol Case Stud· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis